Login
$LENZ
$3.80 -$0.02 (0.52%) After hours

$LENZ SEC Filings

Filed On Filing
05 Nov 2026 SCHEDULE 13G/A
04 Nov 2026 SCHEDULE 13G
03 Nov 2026 Form 4: Chevallard Daniel R., Chief Financial Officer

Granted 652,063 Stock Option (right to buy)

03 Nov 2026 10-Q
02 Nov 2026 SCHEDULE 13D/A
02 Nov 2026 Form 4: Ra Capital MANAGEMENT, L.p., 10% owner and 3 others

Sold 2,718,684 shares ($9.13M)

28 Oct 2026 8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities +1 more

LENZ Therapeutics Reports Third Quarter 2026 Financial Results, Announces Strategic Consumer Marketing Focused Reorganization and CEO Succession

27 Oct 2026 SCHEDULE 13G
21 Oct 2026 SCHEDULE 13G/A
08 Sep 2026 SCHEDULE 13G/A
11 Aug 2026 10-Q
11 Aug 2026 8-K: Results of Operations and Financial Condition

Q2 2026 total revenue of $5.5 million from VIZZ product sales and global license agreements

02 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation

On June 30, 2026, Zach Scheiner notified LENZ Therapeutics, Inc. a Delaware corporation (the “Company”) of his resignation as a member of the Company’s Board of Directors (the “Board”) and from all committees of the Board on which he ser...

26 Jun 2026 SCHEDULE 13G
15 Jun 2026 Form 4: Ra Capital MANAGEMENT, L.p., Director and 4 others

Granted 22,100 Stock Option (right to buy)

15 Jun 2026 Form 4: George Jeffrey P., Director

Granted 22,100 Stock Option (right to buy)

15 Jun 2026 Form 4: Drapkin Kimberlee C, Director

Granted 22,100 Stock Option (right to buy)

15 Jun 2026 Form 4: Mccollum James W, Director

Granted 22,100 Stock Option (right to buy)

15 Jun 2026 Form 4: Thunen Shelley B, Director

Granted 22,100 Stock Option (right to buy)

15 Jun 2026 Form 4: Guerard Frederic, Director

Granted 22,100 Stock Option (right to buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support